Last reviewed · How we verify

NCT03488290: BRAVE

Building Resilience Against ViolencE (BRAVE)

Completed NA Last updated 25 April 2022
What this trial tests

NA trial testing LTP Plus TF-CBT in Post Traumatic Stress Disorder in 300 participants. Completed in 1 September 2021.

Timeline
20 April 2018
Primary endpoint
1 June 2021
1 September 2021

Quick facts

Lead sponsorPakistan Institute of Living and Learning
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment300
Start date20 April 2018
Primary completion1 June 2021
Estimated completion1 September 2021
Sites2 locations across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Pakistan Institute of Living and Learning

Who can join

16 and older, any sex, with Post Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study has both quantitative and qualitative components. The objective of the quantitative study is: To evaluate the effectiveness of Learning Through Play (LTP) Plus culturally adapted Trauma Focused Cognitive Behavior Therapy (TF-CBT) for post-traumatic stress symptoms in parents. The objective of the qualitative study is: To find out facilitators and barriers from the perspective of the participants and other stakeholders (e.g., clinicians, GPs, people delivering the LTP plus TF CBT intervention etc)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Building Resilience Against ViolencE (BRAVE): protocol of a parenting intervention for mothers and fathers with post-traumatic stress disorder in Pakistan.
    Chaudhry N, Farooque S, Kiran T, Eylem-van Bergeijk O, et al · · 2022 · cited 1× · PMID 36618756 · DOI 10.1017/gmh.2021.42

Verify or expand the search:

Other recruiting trials for Post Traumatic Stress Disorder

Currently open trials in the same condition.

Other Pakistan Institute of Living and Learning trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03488290.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing